Comparison of the very long term (>1 year) outcomes of drug-eluting stents for the treatment of bare-metal and drug-eluting stent restenosis Costa Jr J, Sousa A, Moreira A, Alves da Costa R, Cano M, Maldonado G, Campos Neto C, Jardim C, Pavanello R, Sousa J September 30, 2009
Angiographic and intravascular ultrasound findings following implantation of the Endeavor™ zotarolimus-eluting stents in patients from the real-world clinical practice Feres R, Andrade P, Costa R, Costa Jr J, Abizaid A, Staico R, Tanajura L, Siqueira D, Maia J, Lasave L, Sousa A, Sousa J August 14, 2009
EXCELLA™ First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesions Costa Júnior J, Abizaid A, Feres F, Costa R, Seixas A, Maia F, Abizaid An, Tanajura L, Staico R, Siqueira D, Meredith L, Bhat V, Yan J, Ormiston J, Sousa A, Fitzgerald P, Sousa J May 13, 2008
Small coronary arteries treated with sirolimus-eluting stents: one-year results of the PORTO multicentre registry Seabra-Gomes R, Eduardo Sousa J, Sousa A, Teles R, Pereira H, Farto Abreu P, Adao M, Marques A, Gama Ribeiro V, Mourao L, Santos R, Cyrne Carvalho H August 20, 2007
The randomised study of the double dose versus single dose sirolimus-eluting stent for the treatment of diabetic patients with de novo coronary lesions Costa R, Eduardo Sousa J, Abizaid A, Chaves A, Feres F, Sousa A, Musumeci G, Mehran R, Fitzgerald P, Lansky AJ, Leon M, Shiran A, Halon D, Lewis B, Guagliumi G November 20, 2006
New issue EHRA/EAPCI consensus on LAA occlusion, EAPCI Position paper on defining device sucess and more (3D volume-rendered CCTA LAA example) January 17, 2020
Editorial From Paris to Amsterdam: EuroPCR, ESC 2020 and spotlight on “The Cutting Edge of Cardiology” Robert Byrne January 17, 2020
JAA New this week: Inferior caval valve implantation for severe tricuspid regurgitation January 14, 2020
TRIALS BOOK Access some of the latest Trials: EXCEL 5 years, GALILEO, ISAR-REACT 5 ... (The Trials book is supported by Biotronik) January 15, 2020
